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Is Antenatal Screening for Syphilis Still Necessary?      
E Molloy,C Owoeye,S Knowles
Congenital syphilis continues to present a significant public health problem worldwide1,2. The cornerstone of prevention of congenital syphilis is antenatal screening and treatment
of affected mothers with penicillin1,2. If untreated, symptoms develop within weeks or months1. Early congenital syphilis occurs in children between 0 and 2 years old, however
newborns may be asymptomatic and are only identified on routine screening3. If such infants are missed and untreated, they can develop late congenital syphilis after 2 years.
Syphilis is known as the “Great Imitator” and congenital syphilis can present as neurosyphilis, juvenile paresis, optic atrophy, blindness, progressive sensorineural deafness, dental
and skeletal abnormalities1,3. 
All pregnant women booking in Ireland have routine syphilis serology. First line syphilis testing consists of Treponema pallidumparticle agglutination (TPPA) and Rapid plasma
reagin (RPR). If either or both first line tests are reactive, additional confirmatory tests are carried out using Treponema pallidum enzyme immunoassay IgM and total antibody
tests. Non-specific false positive results are identified on the basis of a single positive result which was not reactive in any confirmatory tests. Confirmation of maternal syphilis
infection is based on two positive treponemal antibody tests; generally TPPA and Treponema pallidum total antibody. A positive IgM or high titre RPR result in the absence of a
history of recent treatment suggests recent active disease. 
Infants are considered to be at risk if they were born to mothers who were either IgM positive, had high titre RPR, had inadequate treatment or treatment late in the pregnancy. In
addition, infants at risk of congenital syphilis need additional investigations such as X-Ray of long bones and chest, CSF syphilis test, CSF cell count and protein, fundoscopy,
examination of umbilical cord and placenta1. Every infant with confirmed positive maternal syphilis serology should therefore have syphilis serology at birth which will be repeated
during follow up at 3, 6 and 12 months3. All infants with proven, presumed or highly suspected infection should be treated with 10-14 days of aqueous penicillin G or procaine
penicillinG3.
A diagnosis of congenital syphilis will be considered in the presence of the following: Physical or radiographic evidence of active disease; Serum quantitative non treponemal titre
at least 4-fold greater than maternal titre; Positive IgM antibody test; Reactive CSF VDRL test result or abnormal CSF cell count / protein levels; Positive dark field microscopy
findings or positive findings when staining for Treponema pallidum in placenta or umbilical cord3. False positive syphilis tests are seen in certain acute or chronic infections,
following immunization, in autoimmune diseases, pregnancy, tuberculosis, hepatitis, Lyme disease, rheumatoid arthritis, drug addiction, cross reaction with other treponemes and
other conditions. In these circumstances testing should be repeated in 14-21 days. Newer diagnostic tests such as enzyme immunoassays, polymerase chain reaction have
made diagnosis more sensitive and specific but are not universally available4.
Congenital syphilis was rare in most affluent countries but there has been a recent resurgence in several European countries. In the United Kingdom the reported number of
babies with congenital syphilis increased from 2 in 1996 to 14 in 2005 (1.9 per 100,000 births)3. In Ireland between 2000-2003, 540 cases of infectious syphilis were
identified5. There were 6 (0.4%) congenital cases of syphilis reported between 2000-2005 and intrauterine death was reported in 2 of the 6 cases5. In Sub-Saharan Africa, 4-
15% of pregnant women have syphilis and an estimated 492,000 infants die of congenital syphilis annually6,7. In the UK, universal antenatal screening of pregnant women was
about as cost-effective as targeted screening programmes and is politically more acceptable. In countries with a 1% rate of syphilis seroreactivity among pregnant women, the
estimated cost of antenatal screening and treatment programmes is €0.30 ($0•42) per pregnant woman, and the cost of averting each syphilis associated adverse pregnancy
outcome €50.10 ($70)8. Syphilis promotes transmission of human immunodeficiency virus (HIV)6. The World Development Report cites antenatal screening and treatment for
syphilis as one of the most cost-effective health interventions available as the cost saved per disability adjusted life year is €2.86 ($4) versus €13.73 ($19.20) for HIV9. Tools
to prevent congenital syphilis have been available for more than 50 years, and cost less than €0.75 ($1)6. However babies still die of syphilis. 
Most infants are asymptomatic at birth and there is no clinically useful diagnostic gold standard, the clinician must essentially rely on the maternal case management history to
determine whether treatment is indicated in the asymptomatic infant.10-12 The low prevalence of congenital syphilis in many developed countries may have led to complacency
and lack of a structured approach to management1,3. The Centers for Disease Control (CDC) report on Congenital syphilis in the US from 2002 found that 76.3% of cases had
untreated, inadequately treated or undocumented treatment of maternal syphilis before or during pregnancy (including stillbirths)7. In addition pre-school children in the developed
world will have a high exposure to antibiotics (prevalence 72%; prescription rate 2.2 prescriptions/person per year) predominantly penicilins (40-70% of antibiotic prescriptions),
which we hypothesise may treat undiagnosed cases of congenital syphilis13. A strict follow-up of pregnant women with syphilis before delivery and an active approach to
identifying and treating exposed neonates born to such patients is needed. Future research needs to concentrate on increasing healthcare professionals’ awareness of the serious
preventable sequelae of congenital syphilis in combination with a structured and practical approach to management to enable global syphilis eradication.
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